πŸ‡ΊπŸ‡Έ FDA
Patent

US 6878728

Inhibitors of aspartyl protease

expired A61KA61K31/352A61K31/36

Quick answer

US patent 6878728 (Inhibitors of aspartyl protease) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Apr 12 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/352, A61K31/36, A61K45/06